# THE SHERWIN-WILLIAMS COMPANY (SHW) · Edgar & Edgarette company card

> The Sherwin-Williams Company (SHW) grew revenue 2.1% in FY2025 to $23.6 billion, equity 17.8% of assets, and dividend per share up 6 years running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 89800 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/SHW) · [JSON](https://www.pops4.com/boards/company/SHW.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $23.6B |
| Revenue growth, 1 year | 2.1% |
| Revenue growth per year | 4.3% |
| Operating margin | — |
| Net margin | 10.9% |
| Operating cash flow | $3.5B |
| Capital spending | $798M |
| Free cash flow | $2.7B |
| Cash | $207M |
| Long-term debt | $9.7B |
| Total assets | $25.9B |
| Total equity | $4.6B |
| Equity ÷ assets | 17.8% |
| Return on equity | 55.9% |
| Dividend per share | $3.16 |
| Dividend years rising | 6 |

## Readings, computed from those figures

- Piotroski F: 6 of 9 (solid)
- Beneish M: -2.5 (below the −1.78 line)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: Cash cow now · steady, with strong cash arriving today

## Edgarette's reading

Exposure: revenue $23.6B (FY2025), total debt $9.7B. Experience: revenue up 2.1% on the year, up 4.3% a year over 4 years. Soundness: equity 17.8% of assets, return on equity 55.9%, payout 30.7% of profit, dividend per share up 6 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $21.5B and $25.1B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $20.1B to $26.7B. A statistical range, not company guidance. Against peers (8 filers, $50M+ revenue, its industry group): growth 2.1% against 3.1%.

Range logged 2026-09-26, receipt 12ec8fa9e6e61549, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

No warning filings in the window.

## Recent filings

- 8-K · filed 2026-11-02 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/89800/000119312526443395/0001193125-26-443395-index.htm)
- 10-Q · filed 2026-10-27 · [filing](https://www.sec.gov/Archives/edgar/data/89800/000008980026000056/0000089800-26-000056-index.htm)
- 8-K · filed 2026-10-27 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/89800/000008980026000054/0000089800-26-000054-index.htm)
- 8-K · filed 2026-09-29 · 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/89800/000119312526405960/0001193125-26-405960-index.htm)
- 10-Q · filed 2026-07-28 · [filing](https://www.sec.gov/Archives/edgar/data/89800/000008980026000049/0000089800-26-000049-index.htm)
- 8-K · filed 2026-07-28 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/89800/000008980026000046/0000089800-26-000046-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000089800.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=89800

## Cite

POPS4, Edgar & Edgarette: THE SHERWIN-WILLIAMS COMPANY (SHW) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/SHW. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.